Monthly Archives: June 2007
Zelnorm By Novartis: Risks Outweigh Benefits
Advances in Irritable Bowel Syndrome treatment has brought us many pharmaceutical products such as Zelnorm by Novartis. As we are finding now, sometimes the treatment of IBS has risks that outweigh the benefits.